These findings suggest that transcriptomic differences in Oligo.3 and other non-myelinating oligodendrocytes may precede the onset of AD pathology in high risk individuals, and further transcriptional differences occur at the onset of pTau deposition. This evidence concerns the gene OLIG3 and Alzheimer disease.